SelenoExcell High Selenium Yeast has been standardized with the Division of Cancer Prevention of the National Cancer Institute and is supported by a Clinical Trial Agreement (CTA). As a result of this standardization and resulting CTA, SelenoExcell has been selected as the sole intervention agent in a series of cancer prevention and health related trials.

FDA Qualified Health Claim for selenium and cancer prevention:

(1) Selenium may reduce the risk of certain cancers. Some scientific evidence suggests that consumption of selenium may reduce the risk of certain forms of cancer. However, FDA has determined that this evidence is limited and not conclusive. or,

(2) Selenium may produce anti-carcinogenic effects in the body. Some scientific evidence suggests that consumption of selenium may produce anti-carcinogenic effects in the body. However, FDA has determined that this evidence is limited and not conclusive.

 

Click here to go to the FDA website to view rest of the FDA Qualified Health Claim for selenium and cancer prevention.

On March 9, 2009, the FDA granted a "Letter of No Objection" GRAS petition for SelenoExcell® to be used in the functional food industry.